HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Sarlet Selected Research

Monoclonal Antibodies

6/2014Antiresorptive drugs beyond bisphosphonates and selective oestrogen receptor modulators for the management of postmenopausal osteoporosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Sarlet Research Topics

Disease

4Osteoporosis
07/2014 - 02/2002
2Bone Resorption
07/2014 - 06/2014
1Osteoporotic Fractures
06/2014
1Hip Fractures (Intertrochanteric Fractures)
06/2014
1Postmenopausal Osteoporosis
06/2014
1Secondary Hyperparathyroidism
02/2002

Drug/Important Bio-Agent (IBA)

2strontium ranelate (protelos)IBA
07/2014 - 01/2006
2DenosumabFDA Link
07/2014 - 06/2014
2Vitamin DFDA LinkGeneric
07/2014 - 02/2002
2CalciumIBA
07/2014 - 02/2002
2Diphosphonates (Bisphosphonates)IBA
07/2014 - 06/2014
1Selective Estrogen Receptor Modulators (SERM)IBA
07/2014
1Teriparatide (Parathar)FDA Link
07/2014
1odanacatibIBA
06/2014
1Monoclonal AntibodiesIBA
06/2014
1LigandsIBA
06/2014
1Bone Density Conservation AgentsIBA
06/2014

Therapy/Procedure

1Therapeutics
01/2006